DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Neoral (Cyclosporine) - Life Threatening Events - Suspected Cause - Side Effect Reports

 
 



Index of reports > Life Threatening Events (65)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Neoral (Cyclosporine) life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 65   Next >>

Possible Neoral side effects in female

Reported by a physician from United States on 2012-08-10

Patient: female

Reactions: Sepsis, Myocardial Infarction, Feeling Abnormal

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Neoral



Possible Neoral side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-07

Patient: female

Reactions: Pruritus, Rash, Suicidal Ideation

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Neoral
    Dosage: 100 mg, 2 capsules am, 1 capsule pm
    Administration route: Oral
    Start date: 2010-10-07

Neoral
    Dosage: 2 df, unk



Possible Neoral side effects in 58 year old female

Reported by a physician from France on 2012-07-27

Patient: 58 year old female

Reactions: Central Nervous System Lymphoma

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Neoral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2002-09-01
    End date: 2011-12-01

Cellcept
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2002-01-01
    End date: 2011-12-01

Other drugs received by patient: Dedrogyl; Prednisolone; Potassium Chloride; Nexium



Possible Neoral side effects in female

Reported by a health professional (non-physician/pharmacist) from Argentina on 2012-07-26

Patient: female, weighing 58.0 kg (127.6 pounds)

Reactions: Renal Impairment, Bacteraemia, Ischaemic Stroke, Urinary Tract Infection, Dehydration, Septic Shock, Cardiac Arrest

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Myfortic
    Dosage: 720 mg, bid
    Administration route: Oral
    Start date: 2011-12-16
    End date: 2012-01-24

Neoral
    Dosage: unk
    Indication: Renal Transplant
    Start date: 2012-01-26
    End date: 2012-01-28

Prograf
    Dosage: 10 mg, unk
    Administration route: Oral

Prograf
    Dosage: 4 mg, bid
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2011-12-16
    End date: 2012-01-25



Possible Neoral side effects in female

Reported by a physician from Italy on 2012-07-26

Patient: female, weighing 46.0 kg (101.2 pounds)

Reactions: Encephalitis, Coma, Renal Graft Loss

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Medrol
    Dosage: 4 mg, unk
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2012-06-13

Neoral
    Dosage: 0.75 mg, unk
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2012-06-13

Certican
    Dosage: 1.25 mg, unk
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2012-06-15
    End date: 2012-06-23

Other drugs received by patient: Bactrim; Atenolol; Zovirax; Pantoprazole Sodium



Possible Neoral side effects in male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-18

Patient: male

Reactions: Gastrointestinal Haemorrhage, Disseminated Intravascular Coagulation, Enterococcal Infection, Coagulopathy, Cardiac Failure Acute, Pneumonia Cytomegaloviral, Pneumocystis Jiroveci Pneumonia, Anal Fistula, Colonic Fistula, Acute Respiratory Distress Syndrome, Circulatory Collapse, Apnoea, Melaena, Cytomegalovirus Enterocolitis, Metabolic Acidosis, Gastrointestinal Ulcer Haemorrhage, Restlessness, Hyperglycaemia, Anaemia, Duodenal Ulcer, Ulcer, Delirium, Fungal Infection, Insomnia, Systemic Inflammatory Response Syndrome, Septic Shock, Hypoventilation, Oral Administration Complication, Shock Haemorrhagic, Ileal Ulcer, Interstitial Lung Disease, Large Intestinal Ulcer, Ileal Fistula, Small Intestinal Haemorrhage, Acute Respiratory Failure, Dyspnoea, Diarrhoea, Respiratory Failure, Sepsis, Anal Haemorrhage, Purulence, Hypertension

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Bredinin
    Dosage: 100 mg, daily
    Administration route: Oral
    End date: 2011-03-08

Neoral
    Dosage: 100 mg, daily
    Administration route: Oral
    Start date: 2010-11-18
    End date: 2011-03-15

Rituximab
    Dosage: unk ukn, unk

Prograf
    Dosage: 2 mg, daily
    Administration route: Oral
    End date: 2011-11-17

Prednisolone
    Dosage: 10 mg, unk
    End date: 2011-03-22

Prednisolone
    Dosage: 10 mg, daily
    Administration route: Oral
    End date: 2011-03-18

Neoral
    Dosage: 50 mg, daily
    Administration route: Oral
    Indication: Renal Transplant
    End date: 2011-03-15

Mycophenolate Mofetil
    Indication: Renal Transplant

Other drugs received by patient: Insulin



Possible Neoral side effects in male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-18

Patient: male

Reactions: Gastrointestinal Haemorrhage, Coagulopathy, Disseminated Intravascular Coagulation, Enterococcal Infection, Cardiac Failure Acute, Pneumonia Cytomegaloviral, Anal Fistula, Pneumocystis Jiroveci Pneumonia, Colonic Fistula, Acute Respiratory Distress Syndrome, Circulatory Collapse, Apnoea, Melaena, Cytomegalovirus Enterocolitis, Metabolic Acidosis, Restlessness, Gastrointestinal Ulcer Haemorrhage, Anaemia, Hyperglycaemia, Duodenal Ulcer, Ulcer, Delirium, Fungal Infection, Insomnia, Systemic Inflammatory Response Syndrome, Septic Shock, Hypoventilation, Oral Administration Complication, Shock Haemorrhagic, Ileal Ulcer, Interstitial Lung Disease, Ileal Fistula, Large Intestinal Ulcer, Small Intestinal Haemorrhage, Acute Respiratory Failure, Dyspnoea, Diarrhoea, Respiratory Failure, Sepsis, Purulence, Anal Haemorrhage, Hypertension

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Rituximab
    Dosage: unk ukn, unk

Prednisolone
    Dosage: 10 mg, daily
    Administration route: Oral
    End date: 2011-03-18

Neoral
    Dosage: 50 mg, daily
    Administration route: Oral
    Indication: Renal Transplant
    End date: 2011-03-15

Bredinin
    Dosage: 100 mg, daily
    Administration route: Oral
    End date: 2011-03-08

Mycophenolate Mofetil
    Indication: Renal Transplant

Prograf
    Dosage: 2 mg, daily
    Administration route: Oral
    End date: 2011-11-17

Neoral
    Dosage: 100 mg, daily
    Administration route: Oral
    Start date: 2010-11-18
    End date: 2011-03-15

Prednisolone
    Dosage: 10 mg, unk
    End date: 2011-03-22

Other drugs received by patient: Insulin



Possible Neoral side effects in male

Reported by a physician from Mexico on 2012-07-13

Patient: male, weighing 48.0 kg (105.6 pounds)

Reactions: Jaundice, Gastrointestinal Haemorrhage, Pneumonia, Complications of Transplanted Kidney, Respiratory Failure, Cytomegalovirus Infection, Acute Respiratory Distress Syndrome, Gastritis

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Neoral
    Dosage: 25 mg, bid
    Administration route: Oral
    End date: 2012-06-13

Neoral
    Dosage: 25 mg, bid
    Administration route: Oral
    Start date: 2012-06-18

Prednisone
    Dosage: 15 mg, qd
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2012-05-16
    End date: 2012-06-13

Neoral
    Dosage: 50 mg, bid
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2012-05-02

Prednisone
    Dosage: 15 mg, qd
    Administration route: Oral

Other drugs received by patient: Acyclovir; Myfortic; Bactrim; Amlodipine; Myfortic; Nystatin; Metoprolol Tartrate; Losartan Potassium



Possible Neoral side effects in female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-09

Patient: female, weighing 39.0 kg (85.8 pounds)

Reactions: Renal Impairment, Pneumonia, Cardiac Failure, Hypokalaemia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Exjade
    Dosage: 1000 mg, daily
    Administration route: Oral
    Indication: Iron Overload
    Start date: 2009-05-27
    End date: 2009-07-07

Neoral
    Indication: Myelodysplastic Syndrome

Neoral
    Dosage: 100 mg, daily
    Administration route: Oral
    Indication: Iron Overload
    Start date: 2009-05-27
    End date: 2009-11-24

Exjade
    Dosage: 725 mg, daily
    Administration route: Oral
    Indication: Myelodysplastic Syndrome
    Start date: 2009-09-30
    End date: 2009-11-24

Other drugs received by patient: Blood Transfusion, Auxiliary Products; Primobolan-Depot INJ; Prednisolone Sodium Succinate INJ; RED Blood Cells, Concentrated; RED Blood Cells, Concentrated



Possible Neoral side effects in male

Reported by a physician from Japan on 2012-07-05

Patient: male

Reactions: Lymphoma

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Colchicine
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Remicade
    Indication: Behcet's Syndrome
    Start date: 2007-08-20

Neoral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Remicade
    Start date: 2012-04-01



Possible Neoral side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-04

Patient: female

Reactions: Stress, Rash Pruritic, Suicidal Ideation

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Neoral



Possible Neoral side effects in female

Reported by a physician from Italy on 2012-06-28

Patient: female

Reactions: Central Nervous System Infection, Coma, Convulsion

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Medrol
    Dosage: 4 mg, unk
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2012-06-13

Neoral
    Dosage: 75 mg, bid
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2012-06-13

Other drugs received by patient: Bactrim; Atenolol; Pantoprazole Sodium; Zovirax



Possible Neoral side effects in female

Reported by a physician from Italy on 2012-06-28

Patient: female, weighing 46.0 kg (101.2 pounds)

Reactions: Central Nervous System Infection, Coma

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Neoral
    Dosage: 0.75 mg, unk
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2012-06-13

Certican
    Dosage: 1.25 mg, unk
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2012-06-15
    End date: 2012-06-23

Medrol
    Dosage: 4 mg, unk
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2012-06-13

Other drugs received by patient: Bactrim; Pantoprazole Sodium; Atenolol; Zovirax



Possible Neoral side effects in male

Reported by a physician from Japan on 2012-06-18

Patient: male, weighing 72.0 kg (158.4 pounds)

Reactions: Urine Output Decreased, Pancytopenia, Condition Aggravated, Pyrexia, Ascites, Renal Failure, Renal Impairment, Hepatic Cirrhosis

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Neoral
    Dosage: 420 mg, qd
    Administration route: Oral
    Indication: Aplastic Anaemia
    Start date: 2012-04-13
    End date: 2012-04-19

Neoral
    Dosage: 250 mg, qd
    Administration route: Oral
    Start date: 2012-04-20
    End date: 2012-04-20

Neoral
    Dosage: 125 mg, unk
    Administration route: Oral
    Start date: 2012-05-10
    End date: 2012-05-10

Neoral
    Dosage: 75 mg, unk
    Administration route: Oral
    Start date: 2012-05-11
    End date: 2012-05-13

Neoral
    Dosage: 150 mg, unk
    Administration route: Oral
    Start date: 2012-04-21
    End date: 2012-05-09

Other drugs received by patient: Adrenal Hormone Preparations; Omeprazole; Primobolan-Depot INJ; Diflucan; Losartan Potassium; Sodium Chloride; Corticosteroid NOS; Pursennid; Gran; Pyrinazin; Solu-Medrol; Thymoglobulin; Lactec; Lactec; Omeprazole; Valtrex



Possible Neoral side effects in female

Reported by a consumer/non-health professional from Japan on 2012-06-11

Patient: female

Reactions: Protein Urine Present, Blood Urea Increased, Hyperglycaemia, Muscular Weakness, Loss of Consciousness, Weight Increased, Renal Failure, Cardiac Failure, Oedema, Arthritis Bacterial, Gait Disturbance, Necrotising Fasciitis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Neoral

Other drugs received by patient: Adrenocorticotrophic Hormone; Adrenocorticotrophic Hormone; Corticosteroids



Possible Neoral side effects in female

Reported by a consumer/non-health professional from Japan on 2012-06-06

Patient: female

Reactions: Weight Increased, Protein Urine Present, Renal Failure, Cardiac Failure, Oedema, Arthritis Bacterial, Muscular Weakness, Gait Disturbance, Necrotising Fasciitis, Loss of Consciousness

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Neoral

Other drugs received by patient: Adrenocorticotrophic Hormone; Adrenocorticotrophic Hormone



Possible Neoral side effects in female

Reported by a consumer/non-health professional from Japan on 2012-06-04

Patient: female

Reactions: Weight Increased, Protein Urine Present, Renal Failure, Cardiac Failure, Oedema, Muscular Weakness, Gait Disturbance, Necrotising Fasciitis, Loss of Consciousness

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Neoral

Other drugs received by patient: Adrenocorticotrophic Hormone; Adrenocorticotrophic Hormone



Possible Neoral side effects in 45 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-05-23

Patient: 45 year old female, weighing 60.0 kg (132.0 pounds)

Reactions: Confusional State, Dyskinesia, Hypotonia, Altered State of Consciousness

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Fludarabine Phosphate
    Dosage: 68 mg, unk
    Indication: Cord Blood Transplant Therapy
    Start date: 2012-01-05
    End date: 2012-01-08

Cyclophosphamide
    Dosage: 1905 mg, unk
    Indication: Cord Blood Transplant Therapy
    Start date: 2012-01-05
    End date: 2012-01-06

Thymoglobulin
    Dosage: 476 mg, unk
    Indication: Cord Blood Transplant Therapy
    Start date: 2012-01-09
    End date: 2012-01-10

Neoral
    Dosage: unk
    Start date: 2011-10-29
    End date: 2012-01-15

Targocid
    Dosage: 400 mg, 1x/day
    Start date: 2011-12-27
    End date: 2012-01-15

Vfend
    Dosage: 400 mg, 1x/day
    Indication: Candidiasis
    Start date: 2011-12-30
    End date: 2012-01-15

Cefepime
    Dosage: 6 g, 1x/day
    Indication: Cord Blood Transplant Therapy
    Start date: 2011-12-30
    End date: 2012-01-15



Possible Neoral side effects in female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-05-18

Patient: female, weighing 56.0 kg (123.2 pounds)

Reactions: Abdominal Pain, Body Temperature Increased, Haemorrhage, Disseminated Intravascular Coagulation, Blood Albumin Decreased, Wound Haemorrhage, Postoperative Abscess, Skin Discolouration, C-Reactive Protein Increased, RED Blood Cell Count Decreased, Skin Ulcer, Skin Atrophy, White Blood Cell Count Increased, Blister, Large Intestine Perforation, Blood Lactate Dehydrogenase Increased, Anaemia, Hypotension, Skin Fragility, Protein Total Decreased, Purpura, Nephrotic Syndrome, Haemoglobin Decreased, Impaired Healing, Heart Rate Increased, Sepsis, Platelet Count Decreased, Skin Infection, Necrotising Fasciitis, Escherichia Infection, Shock

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Bredinin
    Dosage: 150 mg, unk
    Administration route: Oral
    Indication: Nephrotic Syndrome
    Start date: 2009-03-11
    End date: 2010-06-02

Neoral
    Dosage: 150 mg, unk
    Administration route: Oral
    Indication: Nephrotic Syndrome
    Start date: 2000-05-01

Prednisolone
    Dosage: 35 mg, unk
    Administration route: Oral
    Indication: Nephrotic Syndrome
    Start date: 1998-01-01

Other drugs received by patient: Slow-K; Humulin R; Steroids NOS; Locholest; Prednisolone; Alendronate Sodium; Lasix; Humulin N



Possible Neoral side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-05-16

Patient: female

Reactions: Confusional State, Dyskinesia, Hypotonia, Altered State of Consciousness

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Neoral
    Start date: 2011-10-29
    End date: 2012-01-15

Fludarabine Phosphate
    Indication: Cord Blood Transplant Therapy
    Start date: 2012-01-05
    End date: 2012-01-08

Vfend
    Start date: 2011-12-30
    End date: 2012-01-15

Cyclophosphamide
    Indication: Cord Blood Transplant Therapy
    Start date: 2012-01-05
    End date: 2012-01-06

Thymoglobulin
    Indication: Cord Blood Transplant Therapy
    Start date: 2012-01-09
    End date: 2012-01-10

Cefepime
    Indication: Cord Blood Transplant Therapy
    Start date: 2011-12-30
    End date: 2012-01-15

Targocid
    Start date: 2011-12-27
    End date: 2012-01-15



Possible Neoral side effects in male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-05-16

Patient: male, weighing 66.0 kg (145.2 pounds)

Reactions: Multi-Organ Failure, Pneumocystis Jiroveci Pneumonia, Gastroenteritis Norovirus, Renal Disorder, Respiratory Failure, Liver Disorder

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Neoral

Other drugs received by patient: Venoglobulin; Meropenem; Prednisolone; Vfend; Rabeprazole Sodium; Pacil



Possible Neoral side effects in female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-05-10

Patient: female, weighing 56.0 kg (123.2 pounds)

Reactions: Abdominal Pain, Body Temperature Increased, Haemorrhage, Disseminated Intravascular Coagulation, Blood Albumin Decreased, Wound Haemorrhage, Postoperative Abscess, RED Blood Cell Count Decreased, C-Reactive Protein Increased, Skin Ulcer, Skin Discolouration, Skin Atrophy, White Blood Cell Count Increased, Blister, Large Intestine Perforation, Hypotension, Anaemia, Blood Lactate Dehydrogenase Increased, Skin Fragility, Purpura, Protein Total Decreased, Nephrotic Syndrome, Haemoglobin Decreased, Impaired Healing, Sepsis, Heart Rate Increased, Platelet Count Decreased, Skin Infection, Necrotising Fasciitis, Escherichia Infection, Shock

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Neoral
    Dosage: 150 mg, unk
    Administration route: Oral
    Indication: Nephrotic Syndrome
    Start date: 2000-05-01

Prednisolone
    Dosage: 35 mg, unk
    Administration route: Oral
    Indication: Nephrotic Syndrome
    Start date: 1998-01-01

Prednisolone
    Dosage: 2 mg, unk
    Administration route: Oral
    Indication: Nephrotic Syndrome
    Start date: 1998-01-01

Bredinin
    Dosage: 150 mg, unk
    Administration route: Oral
    Indication: Nephrotic Syndrome
    Start date: 2009-03-11
    End date: 2010-06-02

Other drugs received by patient: Locholest; Slow-K; Humulin N; Steroids NOS; Lasix; Humulin R; Alendronate Sodium



Possible Neoral side effects in 57 year old female

Reported by a physician from Ireland on 2012-04-24

Patient: 57 year old female

Reactions: Dyslipidaemia, Lymphadenopathy, Mouth Ulceration, Dental Plaque, IGA Nephropathy, Headache, Hepatomegaly, Blood Creatinine Increased, Lethargy, Muscle Spasms, Dyspnoea, Pulmonary Sarcoidosis, Toxicity To Various Agents, Nephrotic Syndrome, Tremor, Anxiety, Antinuclear Antibody Positive, Gingival Pain, Joint Swelling, Lymphoma, Asthenia, Normochromic Normocytic Anaemia, Hypertension

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Toviaz
    Dosage: 4 mg, unk
    Administration route: Oral
    Indication: Hypertonic Bladder

Cyclosporine
    Dosage: 125 mg, 2x/day

Neoral
    Dosage: unk

Neoral
    Dosage: 125mg mane/100mg nocte
    Start date: 2011-04-13

Other drugs received by patient: Calcichew-D3; Lansoprazole; Bumetanide; Fosamax; Acetylsalicylic Acid; Ramipril; Ramipril; Amlodipine; Furosemide; Prednisolone; Alendronate Sodium; Lansoprazole; Lercanidipine; Atorvastatin; Prednisolone; Bumetanide



Possible Neoral side effects in 25 year old male

Reported by a consumer/non-health professional from Japan on 2012-04-23

Patient: 25 year old male, weighing 57.0 kg (125.4 pounds)

Reactions: Eyelid Oedema, Pneumonia Viral, Gastrointestinal Haemorrhage, Hepatic Function Abnormal, Graft Versus Host Disease, Disseminated Intravascular Coagulation, Headache, Pyrexia, Oral Herpes, Pneumonia Cytomegaloviral, Generalised Oedema, Pericardial Effusion, Pneumocystis Jiroveci Pneumonia, Interstitial Lung Disease, Liver Function Test Abnormal, Pleural Effusion, Enterocolitis, Bronchopulmonary Aspergillosis, White Blood Cell Count Decreased, Anaemia, Pulmonary Haemorrhage, Renal Impairment, Platelet Count Decreased, Neutrophil Count Decreased

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Itraconazole
    Dosage: capsule;400-200mg/day(06jul-16jul09)inj.
    Administration route: Oral
    Indication: Prophylaxis
    Start date: 2009-06-06
    End date: 2009-07-16

Foscavir
    Dosage: form:inj1 df= 10 unit nos
    Start date: 2009-07-10
    End date: 2009-07-16

Bactrim
    Dosage: 1df=1tab;800mg/day(02jul-18jul09)inj.
    Administration route: Oral
    Indication: Antibiotic Prophylaxis
    Start date: 2009-04-14
    End date: 2009-07-16

Farom
    Administration route: Oral
    Start date: 2009-04-28
    End date: 2009-05-01

Neoral
    Dosage: 09jul-16jul09. 125mg/day sandimmun:inj:50mg/dy:09jul-16jul09
    Administration route: Oral
    Indication: Prophylaxis
    Start date: 2009-04-14
    End date: 2009-07-08

Sprycel
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2009-04-16
    End date: 2009-07-08

Maxipime
    Start date: 2009-04-24
    End date: 2009-04-27

Other drugs received by patient: Ceftazidime; Solu-Medrol; Ambisome; Piperacillin and Tazobactam; Pentamidine Isethionate; Ganciclovir; Meropenem; Omegacin; Sandimmune; Prednisolone



Possible Neoral side effects in male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-04-20

Patient: male

Reactions: Gastrointestinal Haemorrhage, Enterococcal Infection, Coagulopathy, Disseminated Intravascular Coagulation, Cardiac Failure Acute, Pneumonia Cytomegaloviral, Anal Fistula, Pneumocystis Jiroveci Pneumonia, Colonic Fistula, Circulatory Collapse, Acute Respiratory Distress Syndrome, Apnoea, Melaena, Cytomegalovirus Enterocolitis, Metabolic Acidosis, Restlessness, Gastrointestinal Ulcer Haemorrhage, Hyperglycaemia, Anaemia, Duodenal Ulcer, Ulcer, Delirium, Fungal Infection, Insomnia, Systemic Inflammatory Response Syndrome, Septic Shock, Hypoventilation, Shock Haemorrhagic, Oral Administration Complication, Ileal Ulcer, Large Intestinal Ulcer, Ileal Fistula, Interstitial Lung Disease, Small Intestinal Haemorrhage, Acute Respiratory Failure, Dyspnoea, Respiratory Failure, Diarrhoea, Sepsis, Purulence, Anal Haemorrhage, Hypertension

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Bredinin
    Dosage: 100 mg, daily
    Administration route: Oral
    End date: 2011-03-08

Prednisolone
    Dosage: 10 mg, unk
    End date: 2011-03-22

Prograf
    Dosage: 2 mg, daily
    Administration route: Oral
    Start date: 2006-11-01
    End date: 2011-11-17

Rituximab
    Dosage: unk ukn, unk

Neoral
    Dosage: 100 mg, daily
    Administration route: Oral
    Start date: 2010-11-18
    End date: 2011-03-15

Prednisolone
    Dosage: 10 mg, daily
    Administration route: Oral
    Start date: 2006-11-01
    End date: 2011-03-18

Neoral
    Dosage: 50 mg, daily
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2010-11-18
    End date: 2011-03-15

Other drugs received by patient: Insulin



Possible Neoral side effects in male

Reported by a physician from France on 2012-04-20

Patient: male, weighing 68.0 kg (149.6 pounds)

Reactions: Bronchial Obstruction, Klebsiella Infection, Thrombocytopenia, Post Procedural Haemorrhage, Escherichia Sepsis, Renal Vessel Disorder, Complications of Transplanted Kidney, Wound Dehiscence, Anaemia, Malnutrition, Anastomotic Haemorrhage, Wound Complication, Renal Impairment, Diarrhoea, Cytomegalovirus Infection, Renal Tubular Necrosis, Pneumonia Escherichia, Asthenia, Leukopenia

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Neoral
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2011-02-10

Mycophenolate Mofetil (Cellcept)
    Dosage: 1 g, per day
    Administration route: Oral
    Start date: 2011-03-01
    End date: 2011-03-08

Bactrim
    Dosage: 400 mg, per day
    Administration route: Oral
    Start date: 2011-01-24
    End date: 2011-02-01

RAD 666 / RAD 001a
    Dosage: 3 mg, qd
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2011-02-02
    End date: 2011-02-09

Neoral
    Dosage: 100 mg, qd
    Administration route: Oral
    Start date: 2011-02-27
    End date: 2011-03-16

Neoral
    Dosage: unk

Mycophenolate Mofetil (Cellcept)
    Dosage: 2 g, per day
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2011-01-15
    End date: 2011-02-09

Neoral
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2011-01-17
    End date: 2011-02-01

Prednisone TAB
    Dosage: 40 mg, per day
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2011-01-16

Zantac
    Dosage: 150 mg, per day
    Administration route: Oral
    Start date: 2011-02-02

Valganciclovir
    Dosage: 250 mg, 9qd
    Administration route: Oral
    Start date: 2011-01-29
    End date: 2011-02-01

Nexium
    Dosage: 40 mg, per day
    Administration route: Oral
    Start date: 2011-01-16
    End date: 2011-02-01

Other drugs received by patient: Solu-Medrol; Lasix; Adancor; Esomeprazole Magnesium; Calcidia; Pantoprazole; Aspirin; Sodium Bicarbonate; Amlodipine Besylate; Econazole Nitrate; Amoxicillin; Imodium; Simulect; Eprex; Insulatard NPH Human; Potassium Chloride; Nitroderm; Mirtazapine; Aluminum Hydroxide and Magnesium Trisilicate; Alfuzosin HCL; Cotrim



Possible Neoral side effects in 79 year old female

Reported by a physician from Japan on 2012-04-18

Patient: 79 year old female

Reactions: Disseminated Intravascular Coagulation, Urinary Tract Infection, Sepsis, Platelet Count Decreased, Urinary Retention

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Neoral
    Dosage: 150 mg/ daily
    Administration route: Oral
    Start date: 2011-07-06
    End date: 2011-08-08

Neoral
    Dosage: 100 mg,daily
    Administration route: Oral
    Start date: 2011-08-09

Neoral
    Dosage: 100 mg/ daily
    Administration route: Oral
    Indication: Mixed Connective Tissue Disease
    Start date: 2011-06-28
    End date: 2011-07-05



Possible Neoral side effects in female

Reported by a physician from United States on 2012-04-11

Patient: female, weighing 59.0 kg (129.8 pounds)

Reactions: Death, Arterial Thrombosis, Myocardial Infarction

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Neoral

Other drugs received by patient: Heparin; Inderal; Hydrocortisone; Carafate; Nahco3 (Sodium Bicarbonate); Flagyl; Ativan; Regular Humulin Insulin (Insulin Human); Urokinase; Nitroglycerin; Dopamine HCL



Possible Neoral side effects in female

Reported by a physician from United States on 2012-04-11

Patient: female, weighing 50.0 kg (110.0 pounds)

Reactions: Death, Ventricular Tachycardia, Transplant Rejection, Myocardial Infarction

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Neoral

Other drugs received by patient: Procardia; Mycostatin; Ceftriaxone; Acyclovir; MVI (Multivitamins); Colace (Docusate Sodium); Zantac; Bactrim SS (Bactrim); Lasix



Possible Neoral side effects in female

Reported by a health professional (non-physician/pharmacist) from Norway on 2012-04-09

Patient: female

Reactions: Night Sweats, Weight Decreased, Anaplastic Large Cell Lymphoma T- and Null-Cell Types Stage IV, Lung Disorder, Pleural Effusion, Pyrexia, Abdominal Pain Upper

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Neoral
    Dosage: 100 mg, bid
    Administration route: Oral
    Indication: Behcet's Syndrome
    Start date: 2008-10-01
    End date: 2009-09-25

Imuran
    Dosage: 50 mg, bid
    Administration route: Oral
    Indication: Behcet's Syndrome
    Start date: 2009-09-25
    End date: 2011-11-08

Remicade
    Dosage: 300 mg, unk
    Indication: Behcet's Syndrome
    Start date: 2010-03-19
    End date: 2011-11-08

Other drugs received by patient: Prednisolone; Calcigran Forte; Paralgin Forte; Alendronic Acid



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014